radiology

Mediri is constantly evolving its image data management platform mTRIAL for secure and reliable central reads in clinical studies. Currently, mTRIAL is getting ready for RANO evaluation of low- and high-grade gliomas. Automatic interpolation of segmented volumes and easy annotation of measurements are on board. Stay posted.

An aortic aneurysm or even an aortic dissection is often discovered as an incidental finding on abdominal CT scans. In case of doubt, however, the patient must be treated as quickly as possible. We are developing an automatic, AI-supported evaluation of all abdominal CT images in the cloud, which alerts the physician on duty directly in the event of a critical finding, so that the patient can be prioritised.

The likelihood of breast cancer recurrence is still difficult to predict. Together with nine partners in the EU, we are the first to combine radiological, histo-pathological and clinical data of patients in one model to predict relapse of distant metastases.

We proudly announce the release of our new mTRIAL version. For the first time it incorporates a webbased comprehensive DICOM image viewer for platform independent and real time access of clinical trial data. Central read workflow planning and execution has been upgraded for even more reliable and efficient review of radiological data. mTRIAL 3.4. – ready to support your next image based clinical trial.

In honor of todays International Day of Radiology, we want to thank again the attendees of the 8th International Symposium on Focused Ultrasound (23.10.2022 – 27.10.2022) for valuating the contribution of our colleague Jürgen Jenne. The topic covered the first steps towards an automated and generalized definition of target and areas of risk in tcMRgFUS (transcranial therapy with MR-guided focused ultrasound) for tremor therapy. One part of the presented work was to establish a robust method for fiber tracking on brain MR images.

Our new mTRIAL release will come with a full featured browser based DICOM viewer on board. Designed for clinical trial data management, it supports segmentation, annotation and scoring tasks as defined in the study protocol. The OHIF based tool can be adapted to your personal needs and study requirements.

Curious? Contact us for a free demo via info@mediri.com.

We are excited to announce that mediri is working together with the Universitätsmedizin Mannheim on the project “DeepRAY“. The goal of the project is to extend mediri’s mTRIAL platform for AI-based detection of aneurysms and dissections of the aorta on CT images. This will improve the prognosis of patients with life-threatening changes in the abdominal aorta. The investBW project will run for two years and is funded by the Ministerium für Wirtschaft, Arbeit und Tourismus Baden-Württemberg.

We are delighted to share that we have a new Chief Operations Officer: Julia Müller will from now on take care of mediri’s fortune. She takes over from Prof. Johannes Gregori who will be remaining on board as mediri’s Director of Research.

We are proud to announce that our quality management system was re-certified according to EN ISO 13485. Our Software development processes fulfill the requirements for medical devices.

It’s great to be in-person again. After a meeting on the advances in the ASPIRE project together with GSP and VUmc, mediri enjoyed extensive scientific exchange and insights to latest developments in MRI at ISMRM in London. Also thanks to everyone for joining the ASL Network Dinner during ISMRM 2022.